393512888	393512888	CD	B-NP	O
|	|	NN	I-NP	O
OUOMC	OUOMC	NN	I-NP	O
|	|	NN	I-NP	O
37315623	37315623	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6601501	6601501	CD	B-NP	O
|	|	CC	I-NP	O
4/18/2005	4/18/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ANEMIA	ANEMIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2005	3/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2005	7/6/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
HICKONBOTTOM	HICKONBOTTOM	NN	B-NP	O
,	,	,	O	O
NATHANAEL	NATHANAEL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Panhypopituitarism	Panhypopituitarism	NN	B-NP	O
,	,	,	O	O
easy	easy	JJ	B-NP	O
bruising	bruise	VBG	I-NP	O
,	,	,	O	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema/rash	edema/rash	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
27-year-old	27-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
craniopharyngioma	craniopharyngioma	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
resection	resection	NN	I-NP	O
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	O
11	11	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
panhypopituitarism	panhypopituitarism	NN	B-NP	O
and	and	CC	O	O
cognitive	cognitive	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
difficulty	difficulty	NN	B-NP	O
staying	stay	VBG	B-VP	O
fully	fully	RB	B-ADVP	O
awake	awake	RB	I-ADVP	O
,	,	,	O	O
difficulties	difficulty	NNS	B-NP	O
with	with	IN	B-PP	O
reading	reading	NN	B-NP	O
and	and	CC	I-NP	O
writing	writing	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
short-term	short-term	JJ	B-NP	O
memory	memory	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
easy	easy	JJ	B-NP	O
bruising	bruising	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
nose	nose	NN	I-NP	O
bleeds	bleed	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
packing	packing	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nose	nose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
bruising	bruise	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arms	arm	NNS	I-NP	O
and	and	CC	I-NP	O
feet	foot	NNS	I-NP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
with	with	IN	B-PP	O
standing	standing	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Otherwise	Otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
URI	URI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Craniopharyngioma	Craniopharyngioma	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
resection	resection	NN	I-NP	O
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Ritalin-SR	Ritalin-SR	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Levoxyl	Levoxyl	NN	B-NP	O
274	274	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Aviane	Aviane	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OCP	OCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cortef	Cortef	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

DDAVP	DDAVP	NN	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
0.4	0.4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Melatonin	Melatonin	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

CPAP	CPAP	NN	B-NP	B-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Doz	Doz	NNP	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Provigil	Provigil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Humatrope	Humatrope	JJ	B-NP	B-protein
40	40	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.p.m.	q.p.m.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
too	too	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
and	and	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
graduate	graduate	NN	I-NP	O
student	student	NN	I-NP	O
who	who	WP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
partially	partially	RB	I-NP	O
empty	empty	JJ	I-NP	O
sella	sella	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/76	110/76	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
Appearance	Appearance	NNP	I-NP	O
:	:	:	O	O
Morbidly	Morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
female	female	JJ	I-NP	O
,	,	,	I-NP	O
sleepy	sleepy	JJ	I-NP	O
,	,	,	I-NP	O
arousable	arousable	JJ	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Anicteric	Anicteric	JJ	B-NP	O
sclerae	sclerae	NNS	I-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movement	movement	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
to	to	TO	B-VP	O
auscultation	auscultation	VB	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

CVS	CVS	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	I-NP	O
bradycardiac	bradycardiac	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Benign	Benign	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ankles	ankle	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
erythematous	erythematous	JJ	I-NP	B-protein
skin	skin	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
AND	AND	CC	I-NP	O
DIAGNOSTIC	DIAGNOSTIC	NN	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Chem-7	Chem-7	NN	B-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
2.15	2.15	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
64	64	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Coagulations	Coagulation	NNS	B-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-DNA
56	56	CD	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

UA	UA	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
1-3	1-3	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
10-15	10-15	CD	B-NP	O
casts	cast	NNS	I-NP	O
.	.	.	O	O

UHCG	UHCG	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBN	B-NP	O
sinus	sinus	NN	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
first-degree	first-degree	JJ	B-NP	O
AV	AV	NN	I-NP	O
and	and	CC	O	O
nonspecific	nonspecific	JJ	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
or	or	CC	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

INITIAL	INITIAL	JJ	B-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
AND	AND	CC	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
SUMMARY	SUMMARY	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
27-year-old	27-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
craniopharyngioma	craniopharyngioma	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
resection	resection	NN	I-NP	O
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
panhypopituitarism	panhypopituitarism	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
sleepiness	sleepiness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two-week	two-week	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a.m.	a.m.	NN	B-NP	O
confusion	confusion	NN	I-NP	O
,	,	,	O	O
visual	visual	JJ	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
ataxia	ataxia	NN	B-NP	O
,	,	,	O	O
tinnitus	tinnitus	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
had	have	VBN	I-VP	O
easy	easy	JJ	B-NP	O
bruising	bruising	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
severe	severe	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
epistaxis	epistaxis	NN	B-NP	O
requiring	require	VBG	B-VP	O
cauterization	cauterization	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
pancytopenia	pancytopenia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
swelling	swelling	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hands	hand	NNS	I-NP	O
and	and	CC	I-NP	O
arms	arm	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	O
in	in	IN	B-PP	O
2/17	2/17	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
or	or	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
recurrence	recurrence	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
rheumatologic	rheumatologic	JJ	I-NP	O
,	,	,	I-NP	O
neurologic	neurologic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hematologic	hematologic	JJ	B-NP	O
workup	workup	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
both	both	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
and	and	CC	O	O
unsuccessful	unsuccessful	JJ	B-NP	O
LP	LP	NN	I-NP	O
under	under	IN	B-PP	O
IV	IV	CD	B-NP	O
conscious	conscious	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hypothermic	hypothermic	JJ	I-ADJP	O
about	about	IN	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
on	on	IN	B-PP	O
10/6/05	10/6/05	CD	B-NP	O
for	for	IN	B-PP	O
closer	close	JJR	B-NP	O
observation	observation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
encephalopathic	encephalopathic	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
on	on	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	O	O
cefoxitin	cefoxitin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
acyclovir	acyclovir	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
CT-guided	CT-guided	JJ	I-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
requiring	require	VBG	B-VP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
in	in	IN	B-PP	O
more	more	JJR	B-NP	O
detail	detail	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
below	below	IN	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
and	and	CC	O	O
uses	use	VBZ	B-VP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ceanmin	Ceanmin	NNP	I-NP	O
Chbre	Chbre	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
was	be	VBD	B-VP	O
contacted	contact	VBN	I-VP	O
who	who	WP	B-NP	O
confirmed	confirm	VBD	B-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
clear	clear	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
hypothermic	hypothermic	JJ	B-NP	O
and	and	CC	I-NP	O
unresponsive	unresponsive	JJ	I-NP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
for	for	IN	B-PP	O
CT-guided	CT-guided	JJ	B-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
excessive	excessive	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
was	be	VBD	B-VP	O
quickly	quickly	RB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
oxygenating	oxygenate	VBG	I-VP	O
and	and	CC	I-VP	O
ventilating	ventilate	VBG	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

CPAP	CPAP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CVS	CVS	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/05	6/1/05	CD	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
resting	resting	JJ	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30s	30s	CD	I-NP	O
to	to	TO	I-NP	O
40s	40s	CD	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
vagal	vagal	JJ	I-NP	O
tone	tone	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
consequence	consequence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
atropine	atropine	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
separate	separate	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
instance	instance	NN	I-NP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
getting	get	VBG	B-VP	O
vasoconstrictors	vasoconstrictor	NNS	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
obtain	obtain	VB	I-VP	O
a	a	DT	B-NP	O
dedicated	dedicate	VBN	I-NP	O
EP	EP	NNP	I-NP	O
Service	Service	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
consult	consult	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
vagal	vagal	JJ	B-NP	O
tone	tone	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
responds	respond	VBZ	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
young	young	JJ	I-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
choice	choice	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
3-4	3-4	CD	B-NP	O
second	second	JJ	I-NP	O
pauses	pause	NNS	I-NP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
occasion	occasion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
further	further	JJ	B-NP	O
pauses	pause	NNS	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
revisited	revisit	VBN	I-VP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
keep	keep	VB	I-VP	O
atropine	atropine	NN	B-NP	O
and	and	CC	I-NP	O
Zoll	Zoll	NN	I-NP	O
pads	pad	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
it	it	PRP	B-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
CK-MB	CK-MB	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
since	since	IN	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
presumptive	presumptive	JJ	B-NP	O
meningitis	meningitis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1.0	1.0	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypernatremia	hypernatremia	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
DDAVP	DDAVP	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
fear	fear	NN	B-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
her	her	PRP	B-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP	B-NP	O
somewhat	somewhat	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
155	155	CD	B-NP	O
despite	despite	IN	B-PP	O
getting	get	VBG	B-VP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
repletion	repletion	NN	I-NP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
DDAVP	DDAVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
10/5/05	10/5/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
DDAVP	DDAVP	NN	B-NP	O
of	of	IN	B-PP	O
0.2	0.2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
0.4	0.4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
145	145	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Endocrine	Endocrine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
have	have	VBP	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
not	not	RB	B-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
instead	instead	RB	B-ADVP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
aggressively	aggressively	RB	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
water	water	NN	I-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kearley	Kearley	NNP	I-NP	O
of	of	IN	B-PP	O
Endocrine	Endocrine	NNP	B-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
recheck	recheck	VB	I-VP	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Derm/Rheumatology	Derm/Rheumatology	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
services	service	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
biopsies	biopsy	NNS	B-NP	O
done	do	VBN	B-VP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
locations	location	NNS	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
nonspecific	nonspecific	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
mixed	mixed	JJ	B-NP	O
connective	connective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
serologies	serology	NNS	I-NP	O
have	have	VBP	B-VP	O
,	,	,	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
most	most	JJS	I-NP	O
part	part	NN	I-NP	O
,	,	,	O	O
been	be	VBN	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
presumptively	presumptively	RB	B-ADVP	O
with	with	IN	B-PP	O
stress-dose	stress-dose	JJ	B-NP	O
and	and	CC	I-NP	O
eventually	eventually	RB	I-NP	O
pulse	pulse	NN	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
towards	towards	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
quick	quick	JJ	I-NP	O
taper	taper	NN	I-NP	O
of	of	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
revert	revert	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
panhypopituitarism	panhypopituitarism	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Endocrine	Endocrine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
thyroid	thyroid	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Levoxyl	Levoxyl	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
interpret	interpret	VB	I-VP	O
her	her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
panhypopituitarism	panhypopituitarism	NN	B-NP	O
;	;	:	O	O
therefore	therefore	RB	B-ADVP	O
we	we	PRP	B-NP	O
followed	follow	VBD	B-VP	O
her	her	PRP	B-NP	O
T4	T4	NN	I-NP	O
,	,	,	O	O
T3	T3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
free	free	JJ	B-NP	O
T4	T4	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
illness	illness	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
decreased	decrease	VBN	I-NP	O
free	free	JJ	I-NP	O
T4	T4	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
275	275	CD	B-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
insipidus	insipidus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypernatremia	hypernatremia	NN	I-NP	O
was	be	VBD	B-VP	O
corrected	correct	VBN	I-VP	O
with	with	IN	B-PP	O
D5	D5	NN	B-NP	O
water	water	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
her	her	PRP$	B-NP	O
p.o.	p.o.	NN	I-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
put	put	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
DDAVP	DDAVP	NN	B-NP	B-protein
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Growth	Growth	NN	B-NP	O
hormone	hormone	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
hormone	hormone	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Adrenal	Adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
stress	stress	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
procedures	procedure	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
got	get	VBD	B-VP	O
pulse	pulse	NN	B-NP	O
steroids	steroid	NNS	I-NP	O
per	per	IN	B-PP	O
wound	wound	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
lupus	lupus	NN	B-NP	O
versus	versus	CC	O	O
mixed	mixed	JJ	B-NP	O
connective	connective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
brief	brief	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Gonadotropins	Gonadotropin	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Aviane	Aviane	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OCP	OCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hypersomnolence	hypersomnolence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Neurologic	Neurologic	JJ	I-NP	O
Service	Service	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypercarbic	hypercarbic	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
hypoxic	hypoxic	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
infectious	infectious	JJ	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
entirely	entirely	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EEG	EEG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
nonspecific	nonspecific	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
slowing	slowing	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
seizure	seizure	NN	I-NP	O
foci	focus	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
default	default	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
altered	altered	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
perhaps	perhaps	RB	B-NP	O
even	even	RB	I-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Provigil	Provigil	NNP	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
start	start	VB	I-VP	O
this	this	DT	B-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
returns	return	VBZ	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
stimulants	stimulant	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
fear	fear	NN	B-NP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Ritalin	Ritalin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
once	once	RB	B-ADVP	O
her	her	PRP$	B-NP	O
counts	count	NNS	I-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
recover	recover	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Ritalin-SR	Ritalin-SR	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
,	,	,	I-NP	O
able	able	JJ	I-NP	O
to	to	TO	B-VP	O
converse	converse	VB	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Hematologic	Hematologic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
pancytopenia	pancytopenia	NN	B-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Bone	Bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
,	,	,	O	O
lymphoma	lymphoma	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
myelodysplasia	myelodysplasia	NN	B-NP	O
.	.	.	O	O

Rather	Rather	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
effect	effect	NN	I-NP	O
or	or	CC	I-NP	O
drug	drug	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
counts	count	NNS	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
9.26	9.26	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
27.6	27.6	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
266	266	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
too	too	RB	B-ADVP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
Provigil	Provigil	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Pepcid	Pepcid	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
.	.	.	O	O

Full	Full	JJ	B-ADJP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
CSF	CSF	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
sent	send	VBN	B-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
stool	stool	NN	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
on	on	IN	B-PP	O
9/20/05	9/20/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
antibiotic	antibiotic	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	NNP	B-NP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
DURING	DURING	VBG	B-VP	O
THIS	THIS	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
STAY	STAY	NN	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO/FOLLOWUP	DO/FOLLOWUP	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bodenstein	Bodenstein	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Endocrine	Endocrine	NNP	I-NP	O
Department	Department	NNP	I-NP	O
in	in	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
reached	reach	VBN	I-VP	O
at	at	IN	B-PP	O
842-444-3923	842-444-3923	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
aggressively	aggressively	RB	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
water	water	NN	I-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
her	her	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
biopsy	biopsy	NN	I-NP	O
sutures	suture	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
abdomen	abdoman	NNS	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
forearm	forearm	NN	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
areas	area	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
healed	heal	VBN	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
central	central	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
3/9/05	3/9/05	CD	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pepcid	Pepcid	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Hydrocortisone	Hydrocortisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
x	x	SYM	O	O
4	4	CD	B-NP	O
doses	dose	NNS	I-NP	O
starting	start	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
of	of	IN	B-PP	O
9/10/05	9/10/05	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hydrocortisone	Hydrocortisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
p.m.	p.m.	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Levoxyl	Levoxyl	NN	B-NP	O
275	275	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
x	x	SYM	B-NP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

DDAVP	DDAVP	NN	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
0.4	0.4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

DDAVP	DDAVP	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
spray	spray	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Ritalin-SR	Ritalin-SR	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Aviane	Aviane	NN	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
powder	powder	NN	I-NP	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
b.i.d.	b.i.d.	VBP	B-VP	O
eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-3359749	2-3359749	CD	B-NP	O
IS	IS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MOGEL	MOGEL	NNP	B-NP	O
,	,	,	O	O
NICKY	NICKY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LACORTE	LACORTE	NNP	B-NP	O
,	,	,	O	O
LAWERENCE	LAWERENCE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2983674	2983674	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/1/05	3/1/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/13/05	9/13/05	CD	B-NP	O

